The effect of (+)- and (−)-oxaprotiline administered repeatedly on the dopamine system
- 1 February 1991
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 86 (1) , 11-23
- https://doi.org/10.1007/bf01250372
Abstract
Summary The behavioural and biochemical effects of repeated (14 and 28 days) treatment with (+)-oxaprotiline (a noradrenaline uptake inhibitor) and (−)-oxaprotiline (levoprotiline, without influence on noradrenaline uptake; the clinically active antidepressant) were studied in rats. Both those enantiomers given repeatedly increased the locomotor and exploratory activity and reduced the immobility time in Porsolt's test. The D-amphetamine-induced locomotor hyperactivity, as well as the stereotypies induced by D-amphetamine and apomorphine, were increased by the oxaprotilines. Single-dose treatment with both the oxaprotilines was not effective in the tests mentioned above. Repeated (+)-oxaprotiline administration reduced the binding (Bmax but not KD) to dopamine D-1 receptors in the striatum and limbic system; levoprotiline was inactive. The binding to dopamine D-2 receptors was not changed by either drug. Both the enantiomers showed only low affinity for brain dopamine D-1 and D-2 receptors in vitro. The obtained results indicate that chronic treatment with (+)- and (−)-oxaprotiline increases behavioural responsiveness of the dopamine mesolimbic and striatal systems.Keywords
This publication has 31 references indexed in Scilit:
- Oxaprotiline enantiomers given repeatedly and brain α-adrenoceptorsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Some central pharmacological effects of (+)- and (−)-oxaprotilineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Antidepressants given repeatedly increase the behavioural effect of dopamine D-2 agonistJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- The influence of repeated treatment with imipramine, (+)- and (?)-oxaprotiline on behavioural effects of dopamine D-1 and D-2 agonistsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Enhanced functional responsiveness of the dopaminergic system—the mechanism of anti-immobility effects of antidepressants in the behavioural despair test in the ratNeuropharmacology, 1988
- Single treatments with the antidepressant oxaprotiline and its (+) and (?) enantiomers increase behavioural responses to dopaminergic stimulation in the ratJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Functional supersensitivity to the α1-adrenoceptor agonist after repeated treatment with antidepressant drugs is not conditioned by β-down-regulationNeuropharmacology, 1987
- Repeated treatment with antidepressant drugs increases the behavioural response to apomorphineJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1984
- Antiserotoninergic properties of maprotiline and a new antidepressant, oxaprotiline: Two selective na uptake inhibitorsDrug Development Research, 1981
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973